Literature DB >> 4067301

Type A influenza (H2N2) viruses isolated in Leningrad in 1980.

D B Golubev, G I Karpukhin, S S Galitarov, G M Denisov.   

Abstract

In April-May 1980, two independent outbreaks of influenza-like illness occurred in Leningrad among children's-home children aged from 3 months to 2 years (of 68 children under observation, 50 became ill) and among boarding-school pupils aged 15-17 years (of 50 pupils under observation, 13 became ill). A total of five influenza A virus strains were derived from one clinically healthy and three affected children of the children's home. Similar viruses were obtained from one affected boarding-school pupil and from an infected woman aged 24 years (a sporadic case within a household). On the basis of laboratory findings, all these seven strains were identified as influenza A H2N2 subtype strains. Six of the affected children showed significant seroconversion only to H2 haemagglutinin from February to May 1980. Type A influenza H2N2 virus was isolated from three persons, including the sporadic case, who also showed significant seroconversion to H2 haemagglutinin. H2N2 influenza A virus was isolated on two occasions, at a 7-day interval, from the girl N. Ju. Laboratory findings obtained from the study of the viruses isolated using up-to-date immunological and molecular-biochemical techniques enable us to conclude the following. The A/Leningrad/80 isolates belong to H2N2 sero-subtype. The viruses isolated are similar but not identical to the A/Singapore/I/57 reference strain in details of polypeptide and gene composition.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4067301      PMCID: PMC2129522          DOI: 10.1017/s0022172400062914

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  11 in total

1.  [Optimization of a method for setting up the neuraminidase activity inhibition reaction (author's transl)].

Authors:  M S Paramonova; D B Golubev
Journal:  Vopr Virusol       Date:  1975 Sep-Oct

2.  [Use of the method of differentiating antibodies of different molecular weight for determining the degree of antigenic differences between influenza virus variants].

Authors:  M A Bichurina; L E Nikitina; E A Fridman
Journal:  Vopr Virusol       Date:  1972 Sep-Oct

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Reappearance in 1979 of a 1968 Hong Kong-like influenza virus.

Authors:  B W Moore; R G Webster; W J Bean; K L van Wyke; W G Laver; M G Evered; J C Downie
Journal:  Virology       Date:  1981-02       Impact factor: 3.616

5.  [Phenomenon of the prolonged circulation of the influenza Ao virus in the body].

Authors:  A F Frolov; A M Shcherbinskaia; S L Rybalko; S V Gavrilov; T P Iatel'
Journal:  Mikrobiol Zh       Date:  1978 Jan-Feb

6.  The hemagglutinin of influenza viruses: structure, immunology, and biological function. Summary of a meeting.

Authors:  G Laver
Journal:  J Infect Dis       Date:  1978-07       Impact factor: 5.226

7.  Letter: Influenza A in an isolated population in the Amazon.

Authors:  P A Napiorkowski; F L Black
Journal:  Lancet       Date:  1974-12-07       Impact factor: 79.321

8.  Preparation and properties of antibody directed specifically against the neuraminidase of influenza virus.

Authors:  R G Webster; W G Laver
Journal:  J Immunol       Date:  1967-07       Impact factor: 5.422

9.  Epidemic mechanisms of type A influenza.

Authors:  R E Hope-Simpson
Journal:  J Hyg (Lond)       Date:  1979-08

10.  Differentiation of the haemagglutinin genes of variant influenza viruses by RNA-RNA hybridization.

Authors:  A J Hay; J J Skehel; R G Webster
Journal:  J Gen Virol       Date:  1979-10       Impact factor: 3.891

View more
  2 in total

Review 1.  A new concept of the epidemic process of influenza A virus.

Authors:  R E Hope-Simpson; D B Golubev
Journal:  Epidemiol Infect       Date:  1987-08       Impact factor: 2.451

2.  An open-label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults.

Authors:  Kawsar R Talaat; Ruth A Karron; Philana H Liang; Bridget A McMahon; Catherine J Luke; Bhagvanji Thumar; Grace L Chen; Ji-Young Min; Elaine W Lamirande; Hong Jin; Kathy L Coelingh; George W Kemble; Kanta Subbarao
Journal:  Influenza Other Respir Viruses       Date:  2012-03-14       Impact factor: 4.380

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.